Safety and efficacy of ADS-5102 (amantadine) extended release capsules to improve walking in multiple sclerosis: A randomized, placebo-controlled, phase 2 trial.
| Author | |
|---|---|
| Abstract |
:
Walking impairment causes disability and reduced quality of life in patients with multiple sclerosis (MS). |
| Year of Publication |
:
2018
|
| Journal |
:
Multiple sclerosis (Houndmills, Basingstoke, England)
|
| Number of Pages |
:
1352458518754716
|
| Date Published |
:
2018
|
| ISSN Number |
:
1352-4585
|
| URL |
:
http://journals.sagepub.com/doi/abs/10.1177/1352458518754716?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%3dpubmed
|
| DOI |
:
10.1177/1352458518754716
|
| Short Title |
:
Mult Scler
|
| Download citation |
